KPIs & Operating Metrics(New)
Breakdown Of AssetsEmployee StatisticsFixed Assets, Net BreakdownGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome (Loss) Before Income TaxLicense Revenue By Category AnnualOpex As A % Of Total Revenue %OPEX SegregationProduct Revenue By CategoryProduct Revenue By Category AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Trx By Product
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Gross Profit: 2011-2023

Historic Gross Profit for TherapeuticsMD (TXMD) over the last 12 years, with Dec 2023 value amounting to $502,000.

  • TherapeuticsMD's Gross Profit fell 99.27% to $502,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year decrease of 98.89%. This contributed to the annual value of $1.3 million for FY2023, which is 98.10% down from last year.
  • According to the latest figures from Q4 2023, TherapeuticsMD's Gross Profit is $502,000, which was up 1,047.17% from -$53,000 recorded in Q3 2023.
  • TherapeuticsMD's 5-year Gross Profit high stood at $68.6 million for Q4 2022, and its period low was -$53,000 during Q3 2023.
  • Moreover, its 3-year median value for Gross Profit was $14.2 million (2021), whereas its average is $15.2 million.
  • Per our database at Business Quant, TherapeuticsMD's Gross Profit soared by 702.72% in 2019 and then tumbled by 99.27% in 2023.
  • Over the past 5 years, TherapeuticsMD's Gross Profit (Quarterly) stood at $13.0 million in 2019, then soared by 30.52% to $17.0 million in 2020, then dropped by 17.98% to $13.9 million in 2021, then skyrocketed by 391.83% to $68.6 million in 2022, then plummeted by 99.27% to $502,000 in 2023.
  • Its Gross Profit was $502,000 in Q4 2023, compared to -$53,000 in Q3 2023 and $437,000 in Q2 2023.